• Closing Bell

  • Auteur(s): CNBC
  • Podcast

  • Résumé

  • From the open to the close, “Closing Bell” and “Closing Bell: Overtime” have you covered. From what’s driving market moves to how investors are reacting, Scott Wapner, Morgan Brennan and Jon Fortt guide listeners through each trading session and bring to you some of the biggest names in business.
    2025 CNBC
    Voir plus Voir moins
Épisodes
  • Closing Bell Overtime: Twilio CEO on Earnings, Nvidia’s 13F Moves, & What RFJ Jr. Means For Vaccine Stocks 02/14/25
    Feb 14 2025

    Jefferies Chief Market Strategist David Zervos and RBC Capital Markets Head of US Equity Strategy Lori Calvasina join to break down the market landscape after a wild week. Our Kristina Partsinevelos digs into Nvidia’s latest 13F filing and its shifting investments. Twilio CEO Khozema Shipchandler discusses the company’s earnings results and what kind of AI return the company is seeing in an exclusive interview. Jefferies' Michael Yee weighs in on Moderna, biotech, and the potential RFK impact on markets. Plus, John San Marco previews Walmart’s earnings and the retail outlook amid tariff concerns.

    Voir plus Voir moins
    42 min
  • Closing Bell 02/14/25
    Feb 14 2025

    From the open to the close, “Closing Bell” and “Closing Bell: Overtime” have you covered. From what’s driving market moves to how investors are reacting, Scott Wapner, Jon Fortt, Morgan Brennan and Michael Santoli guide listeners through each trading session and bring to you some of the biggest names in business.

    Voir plus Voir moins
    43 min
  • DraftKings CEO on Earnings, Super Bowl; Zoetis CEO on Avian Flu Vaccine For Poultry 02/13/25
    Feb 13 2025

    Adam Crisafulli and Mike Santoli break down a packed earnings slate, including Airbnb, Roku, Coinbase, and more. Mark Mahaney joins to analyze Airbnb and Roku’s results, while DraftKings CEO Jason Robins weighs in on the company’s latest quarter and the impact from the Super Bowl. Citizens’ analyst Devin Ryan discusses Coinbase’s earnings, and Zoetis CEO Kristin Peck talks tariffs, avian flu, and the company’s portfolio. Plus, our Bertha Coombs reports on the growing coverage for sickle cell gene therapies.

    Voir plus Voir moins
    44 min

Ce que les auditeurs disent de Closing Bell

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.